Clinical trials
Completed Phase 1 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 7 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 12 |
| 2017 | 15 |
| 2018 | 14 |
| 2019 | 9 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| AstraZeneca | 6 |
| Novartis Pharmaceuticals | 5 |
| Xencor, Inc. | 4 |
| Mayo Clinic | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Pfizer | 3 |
| AbbVie | 2 |
| Bayer | 2 |
| City of Hope Medical Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 110 |
| Breast Neoplasms | 43 |
| Carcinoma, Non-Small-Cell Lung | 35 |
| Ovarian Neoplasms | 25 |
| Pancreatic Neoplasms | 17 |
| Carcinoma, Renal Cell | 16 |
| Colorectal Neoplasms | 16 |
| Neoplasms | 16 |
| Squamous Cell Carcinoma of Head and Neck | 16 |
| Melanoma | 14 |
Trials
Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.